TITLE

Neuroleptic malignant syndrome

AUTHOR(S)
Cope, Rosemarie V.; Gregg, Elizabeth M.
PUB. DATE
June 1983
SOURCE
British Medical Journal (Clinical Research Edition);6/18/1983, Vol. 286 Issue 6382, p1938
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports a case of neuroleptic malignant syndrome in Great Britain. Analysis on the case of a 33 year old single man with a paranoid psychosis; Comparison of the syndrome with acute lethal catatonia; Lack of treatment of the disease.
ACCESSION #
5237196

 

Related Articles

  • Zuclopenthixol.  // Reactions Weekly;7/26/2008, Issue 1212, p27 

    The article describes the case of a 17-year-old boy who developed neuroleptic malignant syndrome (NMS) after starting zuclopenthixol for a psychiatric disorder. Treatment with IM zudopenthixol acetate was initiated after the patient presented with psychosis, catatonia and bizarre behaviour. His...

  • Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma. Lang, Fabian; Lang, Silke; Becker, Thomas; Jäger, Markus // Psychopharmacology;Jan2015, Vol. 232 Issue 1, p1 

    Rationale: A substantial overlap exists between catatonic phenomena and features of neuroleptic malignant syndrome. Objectives: The objective of this study is to examine whether catatonia can be distinguished from neuroleptic malignant syndrome and to identify symptoms that may have...

  • Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment. Sahoo, Manoj Kumar; Agarwal, Sanjay; Biswas, Harshita // Industrial Psychiatry Journal;Jul-Dec2014, Vol. 23 Issue 2, p163 

    Catatonia is a syndrome, comprised of symptoms such as motor immobility, excessive motor activity, extreme negativism, and stereotyped movements. Neuroleptic is able to induce catatonia like symptoms, that is, the neuroleptic malignant syndrome (NMS). In NMS, patients typically show symptoms...

  • Delirious Mania and Malignant Catatonia: A Report of 3 Cases and Review. Detweiler, Mark B.; Mehra, Abhishek; Rowell, Thomas; Kim, Kye Y.; Bader, Geoffrey // Psychiatric Quarterly;Mar2009, Vol. 80 Issue 1, p23 

    Delirious mania is often difficult to distinguish from excited catatonia. While some authors consider delirious mania a subtype of catatonia, the distinction between the two entities is important as treatment differs and effects outcome. It appears that as catatonia is described as having...

  • Catatonía periódica o síndrome neuroléptico maligno: claves para un reto diagnóstico. García, Javier Sánchez; de Rezende Borges, Livia; López, Ignacio Vera // Revista de la Asociación Española de Neuropsiquiatría;Jul-Sep2012, Vol. 32 Issue 115, p597 

    Introduction: Psychiatric institutionalized patients suffering severe learning disabilities and coincidental motor symptoms usually represent a challenge in their diagnostic and therapeutic processes. Periodic catatonia may produce neurovegetative and motor symptoms, the first being essential...

  • Catatonia: harbinger of the neuroleptic malignant syndrome. White, Denise A. C.; Robins, Ashley H.; White, D A; Robins, A H // British Journal of Psychiatry;Mar91, Vol. 158, p419 

    Five consecutive cases of the NMS are presented, in all of which a catatonic state preceded the onset of the condition. Catatonia would appear to represent a highly significant risk factor for the NMS and a possible causal link between the two disorders is suggested.

  • Risperidone.  // Reactions Weekly;10/4/2008, Issue 1222, p28 

    The article describes the case of a 56-year-old woman who experienced catatonia and mild neuroleptic malignant syndrome (NMS) after receiving oral risperidone M-tab and long-acting IM risperidone. It references a study by G. D. Mall et al, published in the October 2008 issue of the "Journal of...

  • Clozapine-Associated Neuroleptic Malignant Syndrome Followed by Catatonia: A Case Report. EROL, Almıla; PUTGÜL, Gülperi; SERT, Engin; METE, Levent // Turk Psikiyatri Dergisi;Summer2013, Vol. 24 Issue 2, p1 

    Objective: Neuroleptic malignant syndrome (NMS) is a rare life-threatening condition associated with the use of antipsychotics and other drugs that influence dopaminergic transmission. Although NMS is typically associated with classical antipsychotics, it can also be induced by atypical...

  • Catatonia: A Narrative Review. Fornaro, Michele // Central Nervous System Agents in Medicinal Chemistry;Mar2011, Vol. 11 Issue 1, p73 

    No abstract available.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics